相关实验视频

Updated: Jun 27, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

非小细胞肺癌转移,没有瘤变化

Nikolaj Frost¹, Martin Reck²

¹Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Pulmonary Medicine, Berlin, Germany.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

|April 26, 2024

概括

本综述涵盖非小细胞肺癌的第一线治疗方法,重点关注免疫检查点抑制剂 (ICI) 和耐药性. 它探讨了最佳策略,预测因素和新型疗法,如抗体-药物联合体,以改善患者的治疗结果.

科学领域:

医学瘤学医学瘤学
免疫治疗是一种免疫疗法.
胸部癌症胸部癌症癌症

背景情况:

非小细胞肺癌 (NSCLC) 的治疗环境正在发展,特别是在一线管理方面.
免疫检查点抑制剂 (ICI) 已经彻底改变了NSCLC治疗,但在患者选择,耐药性和长期管理方面仍然存在挑战.
了解治疗耐药性和识别预测生物标志物对于优化患者护理至关重要.

研究的目的:

提供关于NSCLC当前一线治疗策略的全面概述.
解决有关NSCLCICI治疗的关键临床决策问题.
审查新兴的治疗方式和NSCLC治疗的未来方向.

主要方法:

对第一线NSCLC当前治疗方法的文献综述.
分析与ICI治疗相关的临床决策问题.
评估各种治疗策略的证据,包括化疗,ICI和新药.

主要成果:

讨论了PD-L1高NSCLC患者的最佳策略,以及ICI反应的预测因素.
研究了双重检查点封锁和长期响应者安全停止策略的好处.
基于多西的疗法仍然是ICI后治疗的支柱,尽管证据有限;新型药物如抗体-药物合物显示出希望.

结论:

有效管理NSCLC需要仔细考虑患者和瘤特征,以优化ICI治疗.
解决对ICI的原发性和获得性耐药性至关重要,需要进一步研究组合策略和新药.
新兴的无化疗方法和抗体-药物合物代表了NSCLC治疗未来有希望的方向.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...